Komori
Occurring Fact4596Kubota Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

Notice of Change in Major Shareholders

Because the number of shares outstanding and the total number of voting rights increased through the exercise of the 38th series of stock acquisition rights, Kubota Asset Management Co., Ltd.'s voting rights ratio fell from 12.38% to 9.33% while its number of shares held remained unchanged, and it ceased to be a major shareholder. The Company also disclosed that reporting this change had been delayed.

Worth reading
33Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
3.05
Decline in voting rights ratio (percentage points)
Wording
Definitive
How definitive the wording is.

Changes in Major Shareholders

Subject Entity

Kubota Pharmaceutical Holdings Co.,Ltd., 窪田アセットマネージメント株式会社

Occurrence30 June 2026 (record date)
Same day
Awareness or receipt of notice30 June 2026 (the change was confirmed from the shareholder registry)
This disclosure10/13/2026
Cause

This was because 360,000 of the 38th series of stock acquisition rights issued by the Company were exercised, resulting in the issuance of 36,000,000 common shares and an increase in the total number of voting rights held by all shareholders.

Change in voting rights ownership ratio

Shareholders Covered12.38%→9.33%(-3.05pt)

The voting rights ownership percentage is the proportion of the voting rights exercisable at a shareholders' meeting held by the shareholder.

Voting rights ownership percentage before the change

142,857 rights (14,285,700 shares), 12.38%, based on the total number of voting rights held by all shareholders as of 28 February 2026

Voting rights ownership percentage after the change

142,857 rights (14,285,700 shares), 9.33%, based on the total number of voting rights held by all shareholders as of 30 June 2026

Outlook

This is based on the Company's latest shareholder registry, and there are no particular matters to disclose regarding the outlook.

Event that occurred
ItemDetails
Event nameChanges in Major Shareholders
Date of occurrence30 June 2026 (record date)
Date recognized / date notice received30 June 2026 (the change was confirmed from the shareholder registry)
Subject EntityKubota Pharmaceutical Holdings Co.,Ltd., 窪田アセットマネージメント株式会社
CauseThis was because 360,000 of the 38th series of stock acquisition rights issued by the Company were exercised, resulting in the issuance of 36,000,000 common shares and an increase in the total number of voting rights held by all shareholders.
Voting rights ownership percentage before the change142,857 rights (14,285,700 shares), 12.38%, based on the total number of voting rights held by all shareholders as of 28 February 2026
Voting rights ownership percentage after the change142,857 rights (14,285,700 shares), 9.33%, based on the total number of voting rights held by all shareholders as of 30 June 2026
OutlookThis is based on the Company's latest shareholder registry, and there are no particular matters to disclose regarding the outlook.
Items this document does not state (17)
Target Locations / ProductsAmount of Impact on Business PerformanceAccounting period in which recognizedImpact on Earnings ForecastType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityPlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

This was because 36,000,000 common shares were issued upon the exercise of the 38th series of stock acquisition rights, increasing the total number of voting rights held by all shareholders. The Company apologized for the delay in disclosure, stating that the change in major shareholders should have been disclosed without delay.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Change in Major Shareholders | Kubota Pharmaceutical Holdings Co.,Ltd. (4596) timely disclosure | Komori